FREE SHIPPING ON ORDERS OVER $150

glp-1 agonist and dpp-4 inhibitor Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD GLP-1 receptor agonists or DPP-4

$21.75

Quantity
- +
Description

Hamann CR, Chung C, Kaffenberger BH

glp-1 agonist and dpp-4 inhibitor Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD GLP-1 receptor agonists or DPP-4

We compared GLP-1RAs with SGLT2 inhibitors and metformin and found that GLP-1RAs significantly reduced the incidence of major CVEs and mortality rate compared with metformin and second- or third-line glucose-lowering medications

glp-1 agonist and dpp-4 inhibitor Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD GLP-1 receptor agonists or DPP-4

Neumiller, Mindy M

glp-1 agonist and dpp-4 inhibitor Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD GLP-1 receptor agonists or DPP-4

Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6) Lancet

glp-1 agonist and dpp-4 inhibitor Receptor Agonists Have better Outcomes Than DPP4 Inhibitors in T2D patients & CKD GLP-1 receptor agonists or DPP-4

You may also like

tirzepatide

US$ 20.55

4.5 (9 reviews)

recommand products